Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 1 - 10 of 337

Selected Filters:
28 June 2024

Low Selection of HIV PrEP Refills at Private Pharmacies among Clients who Initiated PrEP at Public Clinics: Findings from a mixed-methods study in Kenya

This article from BMC Health Services Research describes the impact of a pilot project to permit oral PrEP users to obtain refills at private pharmacies for an additional fee.

Research

External Link
18 June 2024

Nigeria National Oral PrEP Implementation Plan (2022-24) Assessment Presentation

From October 2023 to April 2024, MOSAIC supported the Federal Ministry of Health to evaluate the National Oral PrEP Implementation Plan (Jan 2022 – Jan 2024). The purpose of the evaluation was to assess the achievement of priority activities stipulated in the National Oral PrEP Implementation Plan (Jan 2022-Jan 2024) against the intended objectives. The…

Monitoring & Evaluation, Normative Guidance/Policies

Presentation
18 June 2024

Nigeria National Oral PrEP Implementation Plan (2022-24) Assessment Report

From October 2023 to April 2024, MOSAIC supported the Federal Ministry of Health to evaluate the National Oral PrEP Implementation Plan (Jan 2022 – Jan 2024). The purpose of the evaluation was to assess the achievement of priority activities stipulated in the National Oral PrEP Implementation Plan (Jan 2022-Jan 2024) against the intended objectives. The…

Monitoring & Evaluation, Normative Guidance/Policies

Document
7 June 2024

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled analysis from 72 global studies

This article from Clinical Infectious Diseases reviews 72 prospective studies of daily oral PrEP (TDF/FTC) to evaluate its impact on HIV-1 incidence, drug resistance, adherence, and bone and renal safety in diverse settings.

Research

External Link
28 May 2024

MOSAIC (Maximizing Options to Advance Informed Choice for HIV Prevention)

Short introduction to MOSAIC, a project working across multiple countries to implement user-centered research and research translation efforts to identify, understand, and remove barriers to new product introduction, access, and use; coordinate and provide technical assistance to global, national, and subnational stakeholders to expedite product launch and scale-up; and strengthen the capacity of a wide…

Research

Document
23 May 2024

Access, Adherence, and Acute HIV Infections: A characterization of seroconversion with PrEP in Eswatini

This poster, presented at the INTEREST conference in Cotonou, Benin in 2024, outlines characteristics of seroconversions by women using oral PrEP or the dapivirine vaginal ring in Eswatini.

Research

Document
22 May 2024

Youth-friendly Services Was the Magic: Experiences of adolescent girls and young women in the community PrEP study, South Africa

This article from Global Public Health describes the results of a study to measure the impact of HIV prevention empowerment counselling on PrEP use by adolescent girls and young women in South Africa.

Research

External Link
21 May 2024

Discontinuation of HIV Oral Pre-exposure Prophylaxis: Findings from programmatic surveillance within two general population HIV programs in Nigeria

This article from BMC Public Health explores the factors associated with discontinuation of oral PrEP within one month of initiation in two large HIV projects in Nigeria.

Research

External Link
21 May 2024

Lessons Learnt from Daily Oral PrEP Delivery to Inform National Planning for PrEP Ring Introduction for Women in Low-income and Middle-income Countries: A qualitative inquiry of international stakeholders

This article from BMJ Global Health synthesises lessons learnt from oral PrEP, based on discussions with international stakeholders, to inform the development of a costed rollout plan template for longer acting PrEP methods, including the dapivirine vaginal ring.

Research

External Link
14 May 2024

Daily Oral PrEP, Event-Driven PrEP, PrEP Ring, and CAB PrEP Template Guidelines (Spanish)

The intent of this document is to provide adaptable guidelines to support the development and adoption of national guidelines that align with World Health Organization (WHO) pre-exposure prophylaxis (PrEP) recommendations and guidance, including those for tenofovir disoproxil fumarate (TDF)-based daily and event-driven oral PrEP, the monthly dapivirine vaginal ring (“PrEP ring” or “the ring”), and…

Normative Guidance/Policies

Document